Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2026 07:00 ET | Source: Ovid Therapeutics Inc.

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant...
June 03, 2026 07:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

BOTHELL, Wash., June 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company developing novel therapeutics to meet...
June 03, 2026 07:00 ET | Source: Joveo

Joveo Introduces AI Talent Campaigns to Help Recruiters Launch Multi-Touch Outreach in Minutes

Joveo Introduces AI Talent Campaigns to Help Recruiters Launch Multi-Touch Outreach in Minutes
June 03, 2026 07:00 ET | Source: JJP Biologics

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Favorable safety and tolerability profile, with rapid onset of clinical activity and therapeutic effects observed in patients with LADData support the start of a Phase 1b clinical trial in rheumatoid...
June 03, 2026 06:53 ET | Source: Kura Oncology, Inc.

Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy

– Preliminary Phase 1a data from darlifarnib + adagrasib demonstrate confirmed, objective response rates of 67% in pancreatic cancer, 50% in non-small cell lung cancer, and 29% in KRAS inhibitor-naïve...
June 03, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
June 03, 2026 05:55 ET | Source: GEN Restaurant Group, Inc.

GEN Restaurant Group Appoints Luke A. Hewko as Chief Financial Officer to Accelerate CPG and Multi-Channel Growth

GEN Restaurant Group Appoints Luke A. Hewko as Chief Financial Officer to Accelerate CPG and Multi-Channel Growth
June 03, 2026 05:24 ET | Source: SNS Insider pvt ltd

Liquid Biopsy Market to Surpass USD 36.78 Billion by 2035 as Precision Oncology and Cancer Diagnostics Drive Growth – SNS Insider

Austin, United States, June 03, 2026 (GLOBE NEWSWIRE) -- “The Liquid Biopsy Market size was valued at USD 6.39 Billion in 2025 and is projected to reach USD 36.78 Billion by 2035, growing at a CAGR...
June 03, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global CRISPR-based Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, June 03, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “CRISPR-based Gene Editing Market Size, Trends and Insights By Product (Kits and...
June 03, 2026 04:00 ET | Source: Czechoslovak Group A.S.

CSG secures major ammunition fuze contracts worth in the high tens of millions of Euros in two NATO countries

Global industrial-technology group CSG has secured two major contracts for the supply of mechanical and electronic fuzes for large-calibre ammunition, with a total value in the high tens of millions...